Abstract Five new alkaloids (1-5) were isolated from the leaves and twigs of Cephalotaxus lanceolata and C. fortunei var. alpina along with 24 known alkaloids. The new structures were elucidated based on spectroscopic data including 1D and 2D NMR, FTIR, UV and MS. These new alkaloids showed no cytotoxicity to HeLa, SGC-7901 gastric cancer, and A-549 lung cancer cell lines.
Introduction
Various constituents of Cephalotaxus genus have been reported, including alkaloids [1] [2] [3] [4] [5] [6] , tropones [7] [8] [9] [10] , lignans [10, 11] , diterpenes [9] , flavonoids [6, 10] . Previous investigations led to approximate 100 Cephalotaxus alkaloids, which were mainly classified into two structural types, i.e., homoerythrina and cephalotaxine-type, and the latter demonstrated remarkable antitumor activities [12] . For example, homoharringtonine among cephalotaxine alkaloids was successfully used to treat acute leukemia. As for homoharringtonine, the side chains played an important role in the anticancer activity of these compounds which possessed H-3 a-configuration. So far only reported cephalezomines G possessed H-3 b-configuration. Both homoerythrina and cephalotaxine had same biogenetic origin. However, most of homoerythrinas almost with H-3 a-configuration reminded us that there were more cephalotaxines with same configuration. As a part of our continuous research for Cephalotaxus alkaloids, five new alkaloids, together with 24 known ones ( Fig. 1) were isolated from leaves and twigs of C. lanceolata and C. fortunei var. alpina. The known alkaloids were identified as drupacine (6) [2] , cephalotaxinone (7) [13] , acetycephalotaxine (8) [14] , cephalezomine J (9) [5] , desmethylcephalotaxine (10) [15] , isocephalotaxinone (11) [16] , 1l-hydroxycephalotaxin (12) [2] , cephalotaxine (13) [17] , lucidinine (14) [18] , comosidine (15) [18] , schelhammeridine (16) [19] , 3-epischelhammeridine (17) [20] , comosine (18) [21] , 3-epicomosine (19) [20] , 3-epischelhammericine (20) [20] , fortunine (21) [22] , taxodine (22) [23] , O-methylschlammericine (23) [13] , cephalezomine M (24) [5] , homoisoharringtonine (25) [24] , homoharingtonine (26) [25] , isoharringtonine (27) [25, 26] , epidesoxyharringtonine (28) [27] , desoxyharringtonine (29) [28] by comparison with literatures.
Results and Discussion
Newly isolates (1) (2) (3) (4) (5) ? at m/z 318.1336), absence of a methyl than that of 6. The HMBC correlations (Fig. 2 ) of the methine signal (d H 4.81) with C-12 (d C 132.4), C-13 (d C 128.6), and C-17 (d C 106.0) allowed its position as C-11. Likewise, the other signal d H 3.38 was assigned to CH-4 based on its HMBC correlations with d C 110.1 (C-14), C-12 and d C 39.2 (C-6). The obvious HMBC correlation between methylene protons (d H 1.37 and 2.23) with C-6 and C-3 attributed it to C-1. The proton signal d H 3.86 was assigned to H-2 based on its correlation with d H 2.23 in the 1 H-1 H COSY (Fig. 2) spectrum. The ketal carbon (d C 106.7) was located at C-3 by its HMBC correlations from H-1, 2 and 4. The HMBC crosspeak of H-11/C-3 showed an oxygen bridge between C-11/C-1 in 1 consistent with its degrees of unsaturation. H-2 was established as b-orientation on the basis of the coupling constant (d, J = 6.4 Hz) of H-2. Consequently, the structure of 1 was confirmed as shown in Fig. 1, and ? , 16 mass units higher than that of 7, further indicated that 3 was an 4-hydroxy cephalotaxinone. Alkaloid 4 showed the similar 13 C NMR data to the known alkaloid acetycephalotaxine (8) [14] , except that a methine signal of 8 was substituted by a quaternary carbon d C 86.1 (s) in 4. Like in 3, the additional hydroxyl of 4 was also located at C-4 by its molecular formula C 20 -14) with d C 86.1 (C-4). The hydroxyl of 3 and 4 adopted a-orientation by the molecular model. The configuration of H-3 in both alkaloids was a-oriented by ROESY correlation between H-3 and H-11. Therefore, 3 and 4 were named cephalotines C and D, respectively.
Six methylenes, 3 methines, a methyoxyl and 5 quaternary carbons in the 13 C NMR spectrum of alkaloid 5 revealed that 5 belongs to homoerythrina-type alkaloids rather than cephalotaxine-type alkaloids [2] . The 13 C NMR and DEPT data of alkaloid 5 were similar to those of comosine (18) None of these compounds showed any significant activity against HeLa, SGC-7901 gastric cancer, and A-549 lung cancer cell lines (IC 50 [ 20 lM).
Experimental Section

General Experimental Procedures
Optical rotations were carried out using a Horiba SEPA-300 polarimeter and JASCO DIP-370 digital polarimeter. UV spectra were recorded on Shimadzu 2401Aspec-trophotometer. IR Spectra were obtained on Brucker Tensor 27 infrared spectrophotometer with KBr pellets. 1 H, 13 C and 2D NMR spectral data were measured on a Bruker Avance III-600, DRX-500, and AM-400 MHz spectrometers with SiMe 4 as an internal standard. HRESIMS data were recorded on an Agilent G6230 TOF MS. Column chromatography (CC) was performed with silica gel (200-300 mesh, Qing-dao Haiyang Chemical Co., Ltd., Qingdao, China). RP-18 silica gel (20-45 lm, Fuji Silysia Chemical Ltd., Japan). Fractions were monitored by TLC on silica gel plates (GF254, Qingdao Haiyang Chemical Co., Ltd.) and spots visualized with Dragendorff's reagent spray. MPLC was employed using a Buchi pump system coupled with RP-18 silica gel packed glass columns(15 9 230 and 26 9 460 mm, respectively). HPLC system was carried out on a Waters HPLC system (Waters 1525E pumps, Waters 2996 photodiode array detector, Waters fraction collector II) using a analytical semipreparative or preparative Sunfire C 18 column (4.6 9 150, 10 9 150, and 19 9 250 mm, respectively).
Plant Materials
Leaves and stems of C. lanceolata and C. fortunei var. alpina were collected from Yunnan Province, P. R. China 
alpina
The air-dried and powdered leaves and stems of C. lanceolata (19 kg) and C. fortunei var. alpina (39 kg) was extracted with MeOH (3 9 50 L, 3 9 100 L, 2 days each) at room temperature, respectively, and the solvent was evaporated in vacuo. The extract was dissolved in 1 % HCl solution (v/v) to pH 2-3, basified with 10 % ammonia solution (v/v) to pH 7-8, and partitioned with EtOAc to afford the crude alkaloids (39 and 198 g ). The alkaloidal extract of C. lanceolata (39 g) was subjected to CC over silica gel (400 g) and eluted with a (12 g ) was applied to C 18 MPLC with a Table 2 13 C NMR spectroscopic data of alkaloids 1-5 (d in ppm) 
Cytotoxicity Assay
Three human cancer cell lines, HeLa, SGC-7901 gastric cancer, and A-549 lung cancer, were used in the cytotoxicity assay. All the cells were cultured in RPMI-1640 or DMEM media (Hyclone, USA), supplemented with 10 % fetal bovine serum (Hyclone, USA) in 5 % CO 2 at 37°C. The cytotoxicity assay was performed according to the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) method in 96-well microplates. Briefly, 100 lL adherent cells were seeded into each well of 96-well cell culture plates and allowed to adhere for 12 h before addition of the test compound/drug. Meanwhile suspended cells were seeded with initial density of 1 9 10 5 cells/mL just before addition of the test compound/drug. Each tumor cell line was exposed to the test compound at concentrations of 0.06, 0.32, 1.60, 8.0, and 40 lM for 48 h. Each of these tests was conducted in triplicate, with cisplatin (sigma, USA) as the positive control. After the end of the treatment period, cell viability was measured and cell growth curve was plotted.
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